Cell Lines for Drug Discovery: Elevating Target-Protein Levels Using Engineered Transcription Factors

This publication has 30 references indexed in Scilit:

• Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic Glioblastoma Cell Lines by an Enhancer with Cell Type-specific DNase I Accessibility
  Published by Elsevier ,2002
• Engineering polydactyl zinc-finger transcription factors
  Nature Biotechnology, 2002
• Patent status of the therapeutically important G-protein-coupled receptors
  Expert Opinion on Therapeutic Patents, 2001
• Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site
  Journal of Biological Chemistry, 2000
• Structure and Developmental Expression of the Mouse CCK-B Receptor Gene
  Biochemical and Biophysical Research Communications, 2000
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
  SLAS Discovery, 1999
• Cholecystokinin receptors
  Cellular and Molecular Neurobiology, 1995
• The crystal structure of a two zinc-finger peptide reveals an extension to the rules for zinc-finger/DNA recognition
  Nature, 1993
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970